Literature DB >> 29284304

Altered Long Non-Coding RNA Transcriptomic Profiles in Ischemic Stroke.

Wenzhen He1, Duncan Wei2, Siqia Chen1, Shunxian Li1, Wenjie Chen1.   

Abstract

A previous study described the important regulatory roles of microRNAs (miRNAs) in ischemic stroke. However, the functional significance of long non-coding RNA (lncRNAs) in ischemic stroke was largely unknown. This study aimed to identify lncRNA profiling and elucidate the regulatory mechanisms in the pathophysiology of stroke. RNA sequencing was performed on the blood of three ischemic stroke patients and three normal controls. Differential expression analysis was used to identify differentially expressed lncRNAs (DElncRNAs) and mRNAs (DEmRNAs). After further correlation and co-expression analysis, the corresponding co-expression networks and miRN-lncRNA-mRNA interaction network were then constructed. The expression of DElncRNAs and DEmRNAs was verified in Gene Expression Omnibus. RNA sequencing and subsequent bioinformatics analysis produced a total of 61 DElncRNAs (14 upregulated and 47 downregulated) and 673 DEmRNAs (432 upregulated and 241 downregulated). LOC105372881 and LOC101929707 were the most highly increased and decreased lncRNAs in ischemic stroke. LncRNA-mRNA co-expression networks were constructed according to 3,008 positively co-expressed and 607 negatively co-expressed lncRNA-mRNA pairs. The DElncRNAs may play roles in the pathways of glycolysis/gluconeogenesis, arrhythmogenic right ventricular cardiomyopathy, adherens junction, lysosome, and hematopoietic cell lineage by regulating their co-expressed mRNAs. Combined with previous data, a miRNA-lncRNA-mRNA interaction network for ischemic stroke was constructed. Based on GSE22255, the expression of six DElncRNAs (CEBPA-AS1, LINC00884, HCG27, MATN1-AS1, HCG26, and LINC01184) and 11 DEmRNAs (TREML4, AHSP, PI3, TESC, ANXA3, OAS1, OAS2, IFI6, ISG15, IFI44L, and LY6E) was similar to the current sequencing data. This study is the first to identify blood lncRNAs in human ischemic stroke using RNA sequencing. The findings may be the foundation for understanding the potential role of lncRNAs in ischemic stroke.

Entities:  

Keywords:  co-expression; ischemic stroke; lncRNA profiling; mRNA profiling

Mesh:

Substances:

Year:  2018        PMID: 29284304     DOI: 10.1089/hum.2017.064

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  18 in total

1.  Silencing the lncRNA Maclpil in pro-inflammatory macrophages attenuates acute experimental ischemic stroke via LCP1 in mice.

Authors:  Yan Wang; Ying Luo; Yang Yao; Yuhua Ji; Liangshu Feng; Fang Du; Xiaoya Zheng; Tao Tao; Xuan Zhai; Yaning Li; Pei Han; Baohui Xu; Heng Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-21       Impact factor: 6.200

Review 2.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

3.  Altered lncRNAs Transcriptomic Profiles in Atherosclerosis-Induced Ischemic Stroke.

Authors:  Wenchen Ruan; Jiayang Wu; Jingjing Su; Yongcheng Jiang; Tao Pang; Jingwei Li
Journal:  Cell Mol Neurobiol       Date:  2020-07-11       Impact factor: 5.046

4.  LncRNA CEBPA-AS1 knockdown prevents neuronal apoptosis against oxygen glucose deprivation/reoxygenation by regulating the miR-455/GPER1 axis.

Authors:  Jun Peng; Zheng-Tao Yu; Rong-Jun Xiao; Qing-Song Wang; Ying Xia
Journal:  Metab Brain Dis       Date:  2022-01-28       Impact factor: 3.584

Review 5.  The Mechanism Underlying the Regulation of Long Non-coding RNA MEG3 in Cerebral Ischemic Stroke.

Authors:  Yanfang Zhao; Yingying Liu; Qili Zhang; Hongliang Liu; Jianing Xu
Journal:  Cell Mol Neurobiol       Date:  2022-01-06       Impact factor: 5.046

Review 6.  Role of lncRNAs in the Development of Ischemic Stroke and Their Therapeutic Potential.

Authors:  Kanika Vasudeva; Anyeasha Dutta; Anjana Munshi
Journal:  Mol Neurobiol       Date:  2021-04-05       Impact factor: 5.590

7.  CEBPA-AS1 Knockdown Alleviates Oxygen-Glucose Deprivation/Reperfusion-Induced Neuron Cell Damage by the MicroRNA 24-3p/BOK Axis.

Authors:  Guangfu Di; Xinjie Yang; Feng Cheng; Hua Liu; Min Xu
Journal:  Mol Cell Biol       Date:  2021-07-23       Impact factor: 4.272

8.  Circular RNA expression profile in blood according to ischemic stroke etiology.

Authors:  Aiora Ostolaza; Idoia Blanco-Luquin; Roberto Muñoz; Maite Mendioroz; Amaya Urdánoz-Casado; Idoya Rubio; Alberto Labarga; Beatriz Zandio; Miren Roldán; Judith Martínez-Cascales; Sergio Mayor; María Herrera; Nuria Aymerich; Jaime Gallego
Journal:  Cell Biosci       Date:  2020-03-10       Impact factor: 7.133

9.  Construction of a long non‑coding RNA‑mediated transcription factor and gene regulatory triplet network reveals global patterns and biomarkers for ischemic stroke.

Authors:  Yuze Cao; Jianjian Wang; Xiaoyu Lu; Xiaotong Kong; Chunrui Bo; Shuang Li; Jie Li; Xuesong Sun; Na Wang; Kuo Tian; Huixue Zhang; Liying Cui
Journal:  Int J Mol Med       Date:  2019-12-09       Impact factor: 4.101

10.  MATN1-AS1 promotes glioma progression by functioning as ceRNA of miR-200b/c/429 to regulate CHD1 expression.

Authors:  Jun Zhu; WeiTing Gu; Cai Yu
Journal:  Cell Prolif       Date:  2019-10-30       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.